Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Thu Jul 06 17:15:49 UTC 2023
by
admin
on
Thu Jul 06 17:15:49 UTC 2023
|
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
U87RX375T5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
U87RX375T5
Created by
admin on Thu Jul 06 17:15:51 UTC 2023 , Edited by admin on Thu Jul 06 17:15:51 UTC 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_96 | 1_176 |
| 1_413 | 1_416 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_2 |
| N | 1_3 |
| N | 1_6 |
| N | 1_9 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
INHIBITOR -> TARGET | |||
|
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
NON-INHIBITOR->OFF TARGET |
Ki
|
||
|
INHIBITOR -> TARGET |
|
||
|
|
INHIBITOR -> TARGET | |||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
BINDING
Kd
|
||
|
INHIBITOR -> TARGET |
methoctramine is a selective muscarinic M2 receptor antagonist
|
||
|
INHIBITOR -> TARGET |
Ki
|
||
|
|
AGONIST -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
|
AGONIST -> TARGET |
|
||
|
|
INHIBITOR->OFF-TARGET |
|
||
|
NON-INHIBITOR->OFF TARGET |
NON-INHIBITOR
Ki
|
||
|
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
|
||
|
ANTAGONIST->TARGET |
Ki
|
||
|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
THRX-195518 possesses activity at target muscarinic receptors that was slightly lower (approximately one-third to one-tenth) than revefenacin.
BINDING
Ki
|
||
|
WEAK INHIBITOR->TARGET |
Ki
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT | CHEMICAL |
|